SEC Form 4 · accession 0001185185-18-001623
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claudia Grimaldi
Officer — Vice President and PFO
Period of report
Aug 30, 2018
Accepted (ET)
Aug 31, 2018 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2018 | S | 116,020 | $2.00 | D | 552,987 | D |
Table II — derivative securities
No Table II lines on this filing.